Baricitinib Shows Long-Term Safety in Severe Alopecia Areata: 4-Year Trial Data Medha Baranwal18 April 2025 9:00 PM ISTUSA: In a significant advancement for the treatment of severe alopecia areata (AA), long-term data from two phase III clinical trials-BRAVE-AA1 and...
Baricitinib and UV-B phototherapy combination effective against severe vitiligo, reveals research Jacinthlyn Sylvia28 Jan 2025 8:30 PM ISTA recent clinical trial found that combining the oral medication baricitinib with narrowband UV-B light therapy significantly improves outcomes for...
Study Confirms Baricitinib's Effectiveness for Severe Alopecia Areata and Advocates for Early Trichoscopy Medha Baranwal17 Sept 2024 9:45 PM ISTItaly: A recent 24-week study conducted in Italy has yielded promising results regarding the effectiveness and safety of baricitinib for patients with...
Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries Ruchika Sharma8 Sept 2024 10:00 AM ISTIndianapolis: Eli Lilly and Company and EVA Pharma have announced that the companies have entered into an agreement to expand access to...
Arthritis drugs may relieve long COVID lung symptoms, claims study Dr. Kamal Kant Kohli2 Aug 2024 8:00 AM ISTUniversity of Virginia School of Medicine researchers have identified a potential treatment for the respiratory symptoms of long COVID after...
Commonly prescribed rheumatoid arthritis drug baricitinib promising for type 1 diabetes patients: NEJM Dr. Kamal Kant Kohli8 Dec 2023 10:45 AM ISTAustralia: Ground-breaking research shows promise as the first disease-modifying treatment of its kind for type 1 diabetes that can be delivered as a...
JAK inhibitors show promising efficacy in rheumatoid arthritis treatment Isra Zaman3 Nov 2023 9:30 AM ISTA retrospective multicenter study conducted by Japanese researchers has found that Janus kinase (JAK) inhibitors, a class of drugs used to treat...
CDSCO Panel Grants Eli Lilly's Protocol Amendment Proposal of Baricitinib Study Dr. Divya Colin8 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
Up-titration of baricitinib may improve hair growth among patients with severe alopecia areata : JAMA Medha Baranwal6 Oct 2023 10:00 AM ISTUSA: A pooled analysis of the BRAVE-AA1 and BRAVE-AA2 trials revealed that severe alopecia areata patients not achieving successful regrowth of scalp...
Baricitinib Effective in Treating Juvenile Idiopathic Arthritis: Lancet Jacinthlyn Sylvia20 Sept 2023 10:45 AM ISTJuvenile Idiopathic Arthritis (JIA) is a challenging condition to treat, especially in cases where traditional therapies fail to provide relief....
JAK inhibitors feasible treatment option for patients with Pyoderma gangrenosum Medha Baranwal1 Jun 2023 2:30 AM ISTBrazil: A recent study has stated that JAK inhibitors could be a potential alternative for treating pyoderma gangrenosum (PG) in certain patients,...
Long-term therapy Baricitinib improves hair growth in severe alopecia areata Jacinthlyn Sylvia5 April 2023 8:00 PM ISTA new study published in the American Journal of Clinical Dermatology suggests that Baricitinib's effectiveness for treating people with severe...
